FunPep Co (4881.T) Akcie Kurz

FunPep KK engages in the research and development of pharmaceutical drugs, functional cosmetics and medical devices. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 14 full-time employees. The company went IPO on 2020-12-25. The main business is to promote research and development of functional peptides, which are the results of research at the Graduate School of Medicine, Osaka University, and to put them into practical use in the business fields such as pharmaceuticals, cosmetics and medical devices. The business model defines its technical area as a functional peptide-based area and a related area that has synergies with it. The Research & Development pipeline is composed of research themes for antibody-inducing peptides and developed products. The firm is engaged in the sale of peptide active ingredients through cosmetic raw material trading companies or sales companies.